New Jersey 2026-2027 Regular Session

New Jersey Assembly Bill A2479

Introduced
1/13/26  

Caption

Permits clinical laboratories to provide certain patients discounts without affecting NJ FamilyCare reimbursement rates or violating NJ FamilyCare rebate prohibitions.

Impact

This bill amends existing laws governing reimbursements by allowing clinical labs to charge or accept lower fees from patients based on demonstrated financial hardship without jeopardizing their reimbursement rates. These changes are crucial for ensuring that labs can continue to serve economically disadvantaged individuals without the risk of running afoul of NJ FamilyCare regulations. By overriding state regulations that currently prevent such practices, the bill aims to foster a more inclusive healthcare environment, particularly for those who are homeless or in extreme poverty.

Summary

Assembly Bill A2479, known as the 'Clinical Laboratory Services Reimbursement and Vulnerable Patient Discount Act', is designed to enable clinical laboratories to offer discounts to certain patients without affecting the reimbursement rates under NJ FamilyCare or violating existing rebate prohibitions. The purpose of the bill is to improve access to lab services for vulnerable populations, such as uninsured, underinsured, and those experiencing financial hardship. It recognizes the critical role that laboratory services play, particularly in providing necessary toxicology testing for individuals dealing with substance use disorders.

Contention

Despite its intentions, the bill has faced scrutiny from those concerned about the implications of altering existing Medicaid reimbursement structures. Critics argue that the changes could complicate compliance with federal regulations, and there are concerns that this could inadvertently lead to increased litigation against clinical laboratories that continue offering discounts. Proponents of the bill assert that it is vital to prevent laboratories from ceasing to provide critical services due to fears of enforcement actions related to current anti-rebate regulations.

Companion Bills

NJ A5132

Carry Over Permits clinical laboratories to provide certain patients discounts without affecting NJ FamilyCare reimbursement rates or violating NJ FamilyCare rebate prohibitions.

NJ S4013

Carry Over Permits clinical laboratories to provide certain patients discounts without affecting NJ FamilyCare reimbursement rates or violating NJ Familycare rebate prohibitions.

NJ S1399

Same As Permits clinical laboratories to provide certain patients discounts without affecting NJ FamilyCare reimbursement rates or violating NJ Familycare rebate prohibitions.

Similar Bills

NJ S1399

Permits clinical laboratories to provide certain patients discounts without affecting NJ FamilyCare reimbursement rates or violating NJ Familycare rebate prohibitions.

NJ A2070

Expands availability of NJ FamilyCare Advantage program.

NJ A2253

Codifies and requires Legislative authorization for reductions in minimum NJ FamilyCare eligibility levels and benefits.

NJ A2249

Establishes NJ FamilyCare Stabilization Fund.

NJ A3591

Requires NJ FamilyCare reimbursement for pediatric medication management services provided for certain children by licensed pharmacist.

NJ S2478

Requires DHS to create English and Spanish-language Internet websites to promote enrollment in affordable health care plans.

NJ A3624

Requires DHS to create English and Spanish-language Internet websites to promote enrollment in affordable health care plans.

NJ A2229

"Healthy Smiles Act"; increases NJ FamilyCare fee-for-service reimbursement rates for pediatric dental services; requires NJ FamilyCare managed care rates for identical services be no less than fee-for-service rates.